Association of Serum Soluble T-cadherin Levels with Metabolic Syndrome in Japanese Participants Undergoing Health Checkups
Low serum 130-kDa sT-cad levels are associated with the presence and accumulation of metabolic syndrome-related abnormalities in a Japanese population undergoing health checkups. Inflammation and lipid abnormalities of metabolic syndrome (high TG and/or low HDL-C) may influence the serum 130-kDa sT-cad levels.
Authors
- Hitoshi Nishizawa (ORCID: https://orcid.org/0000-0002-7845-9693)
- Yoshinari Obata (ORCID: https://orcid.org/0000-0002-3443-3635)
- Hirofumi Nagao (ORCID: https://orcid.org/0009-0001-1261-4160)
- Masahito Iioka
- Keitaro Kawada (ORCID: https://orcid.org/0000-0003-4976-2121)
- Shiro Fukuda (ORCID: https://orcid.org/0000-0003-0712-7154)
- Iichiro Shimomura (ORCID: https://orcid.org/0000-0002-0851-9603)
- Yuya Fujishima (ORCID: https://orcid.org/0000-0003-0028-1757)
- Ryohei Mineo
- Takashi Fujimoto (ORCID: https://orcid.org/0000-0002-9966-6202)
- Koji Yamamoto
- Yūji Matsuzawa
- Yuta Kondo
Institutions
- Sumitomo Hospital (JP)
- Institute for Atherosclerosis Research (RU)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5551/jat.65980
- Citations
- 1
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Japan Agency for Medical Research and Development
- Kowa Company
- Kowa Life Science Foundation
- Novo Nordisk
- Manpei Suzuki Diabetes Foundation
- Novo Nordisk Pharma
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology